Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

The recent volatility in key GLP-1 stocks has put the spotlight on the anxiety Wall Street has about the weight loss market. The market is huge — a potential $150 billion a year by the end of the ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Filled with the top stories to start your day, and emergency news alerts.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Subscribe to Sky Sports to watch live, or stream on NOW. You'll need a subscription that includes Sky Sports F1.

Subscribe to Sky Sports to watch live, or stream on NOW. You'll need a subscription that includes Sky Sports News.